Darrell Triulzi
Overview
Explore the profile of Darrell Triulzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bloch E, Triulzi D, Sachais B, Hod E, Cushing M, Jacobs J, et al.
Transfusion
. 2025 Jan;
65(1):246-248.
PMID: 39834046
No abstract available.
2.
Bromfield B, Tellez R, Hughes D, Brown R, Andrzejewski M, Bawa A, et al.
Hepatol Commun
. 2023 Oct;
7(11).
PMID: 37889553
Background: Thromboelastography (TEG) informs the need for blood product transfusions to prevent procedural bleeding complications in patients with cirrhosis. We aimed to evaluate the impact of using a TEG-based transfusion...
3.
Carson J, Stanworth S, Dennis J, Trivella M, Roubinian N, Fergusson D, et al.
Cochrane Database Syst Rev
. 2021 Dec;
12:CD002042.
PMID: 34932836
Background: The optimal haemoglobin threshold for use of red blood cell (RBC) transfusions in anaemic patients remains an active field of research. Blood is a scarce resource, and in some...
4.
Al-Riyami A, Burnouf T, Yazer M, Triulzi D, Kumas L, Sagdur L, et al.
Vox Sang
. 2021 May;
116(10):e71-e120.
PMID: 34013981
No abstract available.
5.
Al-Riyami A, Burnouf T, Yazer M, Triulzi D, Kumas L, Sagdur L, et al.
Vox Sang
. 2021 May;
116(10):1117-1135.
PMID: 34013968
No abstract available.
6.
Yazer M, Triulzi D, Sperry J, Corcos A, Seheult J
Hematology
. 2021 Mar;
26(1):321-327.
PMID: 33775237
Objectives: To determine the rate of RhD-alloimmunization in injured RhD-negative patients in the age range of childbearing potential who were transfused with at least one unit of RhD-positive red blood...
7.
Mccormick M, Triulzi D
Hematology Am Soc Hematol Educ Program
. 2020 Dec;
2020(1):523-526.
PMID: 33275693
No abstract available.
8.
Esper S, Wallisch 4th W, Ryan J, Sanchez P, Sciortino C, Murray H, et al.
Vox Sang
. 2020 Nov;
116(4):440-450.
PMID: 33215723
Background: Studies examining one-year mortality respecting component blood transfusion are sparse. We hypothesize that component blood product transfusions are negatively associated with 90-day and 1-year survival for all patients requiring...
9.
Zuchelkowski B, Wang L, Gingras S, Xu Q, Yang M, Triulzi D, et al.
PLoS One
. 2020 Oct;
15(10):e0240266.
PMID: 33007039
Background: Hydroxychloroquine (HCQ) is widely used in the treatment of malaria, rheumatologic disease such as lupus, and most recently, COVID-19. These uses raise concerns about its safe use in the...
10.
Angus D, Buzgau A, Cheng A, Higgins A, Hullegie S, Lawler P, et al.
JAMA
. 2020 Sep;
324(13):1317-1329.
PMID: 32876697
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, And Participants: An...